GLPwatch
Trials (2081)
Page 2 of 35.
- Analyse the Effect of Semaglutide on Vascular Structure and Function in Patients With Early Type 2 Diabetes
- A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
- The Effect of Different Diets on Arterial Stiffness in Obese Patients on Semaglutide
- Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects
- A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus
- GLP1R-imaging in Hypoglycemia
- The Differential Effects of Diabetes Therapy on Inflammation
- A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy
- A Clinical Trial Looking at the Comparability of 2 Different Forms of Semaglutide
- Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.
- Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
- Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
- Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV
- Natriuretic Effect of GLP-1in Healthy Non Obese Subjects
- Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide
- A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 Diabetes
- Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination
- Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes
- Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation
- Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome
- The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes
- Sequential or CombinaTion Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)
- Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal Insulins
- A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4)
- A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
- Lifestyle Counseling and Medication for Adolescent Weight Management
- Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes
- Reversal to Normoglycemia by Treating Prediabetes
- Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese Patients
- Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
- Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM
- A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With Obesity
- WeDosify Real World Evidence (RWE) Study: Personalized Semaglutide Dosing in U.S. Adults
- Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes
- Outcome of Overweight AF Patients Following Ablation With a Potential Weight Loss Medication ( GOAL-AF )
- Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes
- Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity
- Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)
- A Study of HM11260C in Healthy Male Subject
- Effect of Liraglutide on the Metabolic Profile in Patients With Type 2 Diabetes and Cardiovascular Disease
- A Research Study to Look at How CagriSema Influences Food Intake, Appetite and Emptying of the Stomach in People With Excess Body Weight
- Semaglutide as an Adjunct to Dieting in the Treatment of Type 2 Diabetes
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Denmark and Sweden, as Part of Local Clinical Practice (SURE DENMARK/SWEDEN)
- GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
- Study of Tirzepatide for Recovery and Alcohol Use Management
- A Study to Compare Methodologies for Assessing Glucose-Dependent Insulin Secretion (0000-104)(COMPLETED)
- The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET
- A Research Study to Understand How People With Type 2 Diabetes Take Ozempic® and if the Ozempic®App Helps Them Stay on This Treatment
- A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (C) Semaglutide Tablets
- Characteristics and Treatment Experiences of Individuals Using Injectable Semaglutide for Weight Management, a Cross-sectional Time-series Analysis, Multi-country Study.
- Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
- DUTCH Weight Control in Atrial Fibrillation Study
- A Feasibility Study to Determine the Most Appropriate Digital Dietary Assessment Tool in Patients With Obesity Initiating GLP-1 Receptor Agonist Treatment
- Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes
- Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)
- Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease
- Post Marketing Surveillance Study of Byetta ™ (Exenatide) Use Among Filipino Patients
- Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 Diabetes
- Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes
- Role of Exenatide in NASH-a Pilot Study